Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease
Clinical trial NCT04102579 · COMPLETED
Trial details
- NCT number
- NCT04102579
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2021-10-15
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.